Skip to Content

Notice

National Cancer Institute's Best Practices for Biospecimen Resources

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

National Institutes of Health (NIH), National Cancer Institute (NCI).

ACTION:

Notice with request for comment.

SUMMARY:

As part of the commitment to maintaining current and scientifically accurate best practices, the National Cancer Institute (NCI) is seeking public comment on a revised version of the NCI Best Practices for Biospecimen Resources. This revised version of the NCI Best Practices is intended to both respond to comments received from the biospecimen resource community and provide more current and detailed recommendations related to biospecimen and data quality. Major revisions include the addition of new sections on Biospecimen Resource Management and Operations and Conflict of Interest, expansion of recommendations related to Custodianship and Informed Consent based on NCI workshops, addition of current references throughout the document and harmonization with current federal guidance documents and recommendations from international biospecimen organizations.

DATES:

Effective Date: The updated NCI Best Practices for Biospecimen Resources are open for public comment for a period of 30 days. Comments must be received by September 22, 2010 in order to ensure consideration. After the public comment period has closed, the comments received by NCI will be considered in a timely manner by the NCI Office of Biorepositories and Biospecimen Research. Subsequently, appropriate changes will be made on the Best Practices Web site http://biospecimens.cancer.gov/​bestpractices/​.

ADDRESSES:

Comments submitted via e-mail should use nciobbr@mail.nih.gov and enter “NCI Best Practices” in the subject line. While NCI prefers that comments be sent by email, NCI will accept written comments. Written comments may be sent to: NCI/OBRR, NIH, 11400 Rockville Pike, Rockwall I Building, Bethesda, MD 20892, Attn: Dr. Nicole Lockhart.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Implementation assistance and inquiries should be directed to senior staff of the relevant NCI Extramural and Intramural Program offices.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The NCI Best Practices for Biospecimen Research Start Printed Page 51831may be found online at http://biospecimens.cancer.gov/​bestpractices/​.

Start Signature

Dated: August 12, 2010.

Douglas R. Lowy,

Deputy Director, National Cancer Institute, National Institutes of Health.

End Signature End Supplemental Information

[FR Doc. 2010-20872 Filed 8-20-10; 8:45 am]

BILLING CODE 4140-01-P